nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—ulcerative colitis	0.439	0.804	CbGaD
Naloxone—ALB—ulcerative colitis	0.0548	0.1	CbGaD
Naloxone—ABCB1—ulcerative colitis	0.0523	0.0958	CbGaD
Naloxone—SLCO1A2—Prednisolone—ulcerative colitis	0.0309	0.104	CbGbCtD
Naloxone—SLCO1A2—Hydrocortisone—ulcerative colitis	0.0293	0.099	CbGbCtD
Naloxone—SLCO1A2—Prednisone—ulcerative colitis	0.0292	0.0986	CbGbCtD
Naloxone—CYP2C8—Nicotine—ulcerative colitis	0.0187	0.0634	CbGbCtD
Naloxone—SLCO1A2—Dexamethasone—ulcerative colitis	0.0182	0.0616	CbGbCtD
Naloxone—CYP3A4—Budesonide—ulcerative colitis	0.0175	0.059	CbGbCtD
Naloxone—CYP2C8—Cholecalciferol—ulcerative colitis	0.0168	0.0568	CbGbCtD
Naloxone—ALB—Prednisone—ulcerative colitis	0.0151	0.051	CbGbCtD
Naloxone—ABCB1—Methylprednisolone—ulcerative colitis	0.013	0.044	CbGbCtD
Naloxone—CYP2C8—Hydrocortisone—ulcerative colitis	0.0117	0.0395	CbGbCtD
Naloxone—ABCB1—Betamethasone—ulcerative colitis	0.00847	0.0286	CbGbCtD
Naloxone—ABCB1—Prednisolone—ulcerative colitis	0.00836	0.0282	CbGbCtD
Naloxone—ABCB1—Hydrocortisone—ulcerative colitis	0.00792	0.0268	CbGbCtD
Naloxone—ABCB1—Prednisone—ulcerative colitis	0.00789	0.0267	CbGbCtD
Naloxone—CYP3A4—Methylprednisolone—ulcerative colitis	0.0078	0.0264	CbGbCtD
Naloxone—CYP3A4—Nicotine—ulcerative colitis	0.0076	0.0257	CbGbCtD
Naloxone—CYP2C8—Dexamethasone—ulcerative colitis	0.00728	0.0246	CbGbCtD
Naloxone—CYP3A4—Cholecalciferol—ulcerative colitis	0.00682	0.023	CbGbCtD
Naloxone—CYP3A4—Triamcinolone—ulcerative colitis	0.00591	0.02	CbGbCtD
Naloxone—CYP3A4—Betamethasone—ulcerative colitis	0.00507	0.0171	CbGbCtD
Naloxone—CYP3A4—Prednisolone—ulcerative colitis	0.00501	0.0169	CbGbCtD
Naloxone—ABCB1—Dexamethasone—ulcerative colitis	0.00493	0.0166	CbGbCtD
Naloxone—CYP3A4—Hydrocortisone—ulcerative colitis	0.00475	0.016	CbGbCtD
Naloxone—CYP3A4—Prednisone—ulcerative colitis	0.00473	0.016	CbGbCtD
Naloxone—CYP3A4—Dexamethasone—ulcerative colitis	0.00295	0.00997	CbGbCtD
Naloxone—Withdrawal syndrome—Nicotine—ulcerative colitis	0.00208	0.0365	CcSEcCtD
Naloxone—Sneezing—Nicotine—ulcerative colitis	0.00157	0.0275	CcSEcCtD
Naloxone—Ache—Budesonide—ulcerative colitis	0.0013	0.0227	CcSEcCtD
Naloxone—Drug dependence—Hydrocortisone—ulcerative colitis	0.00125	0.0219	CcSEcCtD
Naloxone—Drug dependence—Methylprednisolone—ulcerative colitis	0.00117	0.0205	CcSEcCtD
Naloxone—Sneezing—Budesonide—ulcerative colitis	0.00108	0.019	CcSEcCtD
Naloxone—Rhinorrhoea—Nicotine—ulcerative colitis	0.00107	0.0188	CcSEcCtD
Naloxone—Drug dependence—Betamethasone—ulcerative colitis	0.00107	0.0187	CcSEcCtD
Naloxone—Drug dependence—Dexamethasone—ulcerative colitis	0.00107	0.0187	CcSEcCtD
Naloxone—Ache—Mesalazine—ulcerative colitis	0.00106	0.0185	CcSEcCtD
Naloxone—Drug dependence—Prednisone—ulcerative colitis	0.00093	0.0163	CcSEcCtD
Naloxone—Abdominal cramps—Mesalazine—ulcerative colitis	0.000722	0.0126	CcSEcCtD
Naloxone—Hot flush—Nicotine—ulcerative colitis	0.000676	0.0118	CcSEcCtD
Naloxone—Menopausal symptoms—Nicotine—ulcerative colitis	0.00067	0.0117	CcSEcCtD
Naloxone—TLR4—liver—ulcerative colitis	0.000627	0.147	CbGeAlD
Naloxone—Withdrawal syndrome—Prednisone—ulcerative colitis	0.000618	0.0108	CcSEcCtD
Naloxone—Irritability—Nicotine—ulcerative colitis	0.000603	0.0106	CcSEcCtD
Naloxone—Rhinorrhoea—Mesalazine—ulcerative colitis	0.000602	0.0105	CcSEcCtD
Naloxone—Sneezing—Triamcinolone—ulcerative colitis	0.00059	0.0103	CcSEcCtD
Naloxone—Nasopharyngitis—Nicotine—ulcerative colitis	0.000565	0.00989	CcSEcCtD
Naloxone—Hyperkinesia—Budesonide—ulcerative colitis	0.000523	0.00915	CcSEcCtD
Naloxone—CREB1—epithelium—ulcerative colitis	0.000487	0.114	CbGeAlD
Naloxone—CREB1—smooth muscle tissue—ulcerative colitis	0.000469	0.11	CbGeAlD
Naloxone—Coma—Mesalazine—ulcerative colitis	0.000446	0.0078	CcSEcCtD
Naloxone—Irritability—Budesonide—ulcerative colitis	0.000415	0.00727	CcSEcCtD
Naloxone—Cardiac disorder—Nicotine—ulcerative colitis	0.000406	0.0071	CcSEcCtD
Naloxone—Flushing—Nicotine—ulcerative colitis	0.000406	0.0071	CcSEcCtD
Naloxone—Mediastinal disorder—Nicotine—ulcerative colitis	0.000394	0.0069	CcSEcCtD
Naloxone—Nasopharyngitis—Budesonide—ulcerative colitis	0.000389	0.00681	CcSEcCtD
Naloxone—Mental disorder—Nicotine—ulcerative colitis	0.000383	0.0067	CcSEcCtD
Naloxone—CREB1—lymphoid tissue—ulcerative colitis	0.000375	0.0877	CbGeAlD
Naloxone—Tension—Nicotine—ulcerative colitis	0.000374	0.00654	CcSEcCtD
Naloxone—CREB1—digestive system—ulcerative colitis	0.000371	0.0866	CbGeAlD
Naloxone—Nervousness—Nicotine—ulcerative colitis	0.00037	0.00647	CcSEcCtD
Naloxone—Tremor—Nicotine—ulcerative colitis	0.000357	0.00624	CcSEcCtD
Naloxone—Agitation—Nicotine—ulcerative colitis	0.00035	0.00612	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000332	0.00581	CcSEcCtD
Naloxone—Convulsion—Nicotine—ulcerative colitis	0.00033	0.00577	CcSEcCtD
Naloxone—Hypertension—Nicotine—ulcerative colitis	0.000329	0.00575	CcSEcCtD
Naloxone—Nasopharyngitis—Mesalazine—ulcerative colitis	0.000317	0.00554	CcSEcCtD
Naloxone—Pulmonary oedema—Prednisolone—ulcerative colitis	0.000316	0.00553	CcSEcCtD
Naloxone—Skin disorder—Mercaptopurine—ulcerative colitis	0.000311	0.00545	CcSEcCtD
Naloxone—Pulmonary oedema—Hydrocortisone—ulcerative colitis	0.000309	0.0054	CcSEcCtD
Naloxone—Nervous system disorder—Nicotine—ulcerative colitis	0.000305	0.00533	CcSEcCtD
Naloxone—Tachycardia—Nicotine—ulcerative colitis	0.000303	0.00531	CcSEcCtD
Naloxone—Hyperhidrosis—Nicotine—ulcerative colitis	0.0003	0.00526	CcSEcCtD
Naloxone—Hydromorphone—PTGS1—ulcerative colitis	0.000299	0.388	CrCbGaD
Naloxone—Pulmonary oedema—Triamcinolone—ulcerative colitis	0.000291	0.00509	CcSEcCtD
Naloxone—Pulmonary oedema—Methylprednisolone—ulcerative colitis	0.00029	0.00508	CcSEcCtD
Naloxone—Flushing—Budesonide—ulcerative colitis	0.000279	0.00489	CcSEcCtD
Naloxone—Cardiac disorder—Budesonide—ulcerative colitis	0.000279	0.00489	CcSEcCtD
Naloxone—Paraesthesia—Nicotine—ulcerative colitis	0.000279	0.00488	CcSEcCtD
Naloxone—Dyspnoea—Nicotine—ulcerative colitis	0.000277	0.00485	CcSEcCtD
Naloxone—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000277	0.00484	CcSEcCtD
Naloxone—CREB1—liver—ulcerative colitis	0.000276	0.0645	CbGeAlD
Naloxone—Angiopathy—Budesonide—ulcerative colitis	0.000273	0.00478	CcSEcCtD
Naloxone—Depression—Mesalazine—ulcerative colitis	0.000272	0.00476	CcSEcCtD
Naloxone—Mediastinal disorder—Budesonide—ulcerative colitis	0.000271	0.00475	CcSEcCtD
Naloxone—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000268	0.00469	CcSEcCtD
Naloxone—Pain—Nicotine—ulcerative colitis	0.000266	0.00465	CcSEcCtD
Naloxone—Mental disorder—Budesonide—ulcerative colitis	0.000264	0.00462	CcSEcCtD
Naloxone—Pulmonary oedema—Dexamethasone—ulcerative colitis	0.000264	0.00462	CcSEcCtD
Naloxone—Pulmonary oedema—Betamethasone—ulcerative colitis	0.000264	0.00462	CcSEcCtD
Naloxone—Sweating—Mesalazine—ulcerative colitis	0.000262	0.00458	CcSEcCtD
Naloxone—Tension—Budesonide—ulcerative colitis	0.000257	0.0045	CcSEcCtD
Naloxone—Nervousness—Budesonide—ulcerative colitis	0.000255	0.00446	CcSEcCtD
Naloxone—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000253	0.00444	CcSEcCtD
Naloxone—Tremor—Budesonide—ulcerative colitis	0.000246	0.0043	CcSEcCtD
Naloxone—Body temperature increased—Nicotine—ulcerative colitis	0.000246	0.0043	CcSEcCtD
Naloxone—Abdominal pain—Nicotine—ulcerative colitis	0.000246	0.0043	CcSEcCtD
Naloxone—Cardiac arrest—Prednisolone—ulcerative colitis	0.000245	0.00429	CcSEcCtD
Naloxone—Mediastinal disorder—Azathioprine—ulcerative colitis	0.000242	0.00424	CcSEcCtD
Naloxone—Chills—Azathioprine—ulcerative colitis	0.000241	0.00422	CcSEcCtD
Naloxone—Agitation—Budesonide—ulcerative colitis	0.000241	0.00422	CcSEcCtD
Naloxone—Irritability—Hydrocortisone—ulcerative colitis	0.00024	0.00421	CcSEcCtD
Naloxone—Cardiac arrest—Hydrocortisone—ulcerative colitis	0.000239	0.00419	CcSEcCtD
Naloxone—Pulmonary oedema—Prednisone—ulcerative colitis	0.00023	0.00402	CcSEcCtD
Naloxone—Cardiac disorder—Mesalazine—ulcerative colitis	0.000227	0.00398	CcSEcCtD
Naloxone—Hypertension—Budesonide—ulcerative colitis	0.000226	0.00396	CcSEcCtD
Naloxone—Irritability—Methylprednisolone—ulcerative colitis	0.000226	0.00395	CcSEcCtD
Naloxone—Cardiac arrest—Triamcinolone—ulcerative colitis	0.000225	0.00394	CcSEcCtD
Naloxone—Hyperkinesia—Prednisone—ulcerative colitis	0.000225	0.00394	CcSEcCtD
Naloxone—Cardiac arrest—Methylprednisolone—ulcerative colitis	0.000225	0.00394	CcSEcCtD
Naloxone—Asthenia—Nicotine—ulcerative colitis	0.000223	0.0039	CcSEcCtD
Naloxone—Angiopathy—Mesalazine—ulcerative colitis	0.000222	0.00389	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000222	0.00388	CcSEcCtD
Naloxone—Mediastinal disorder—Mesalazine—ulcerative colitis	0.000221	0.00386	CcSEcCtD
Naloxone—Chills—Mesalazine—ulcerative colitis	0.00022	0.00385	CcSEcCtD
Naloxone—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000219	0.00384	CcSEcCtD
Naloxone—Mental disorder—Mesalazine—ulcerative colitis	0.000215	0.00375	CcSEcCtD
Naloxone—Diarrhoea—Nicotine—ulcerative colitis	0.000213	0.00372	CcSEcCtD
Naloxone—Nervous system disorder—Budesonide—ulcerative colitis	0.00021	0.00367	CcSEcCtD
Naloxone—Tension—Mesalazine—ulcerative colitis	0.000209	0.00366	CcSEcCtD
Naloxone—Tachycardia—Budesonide—ulcerative colitis	0.000209	0.00365	CcSEcCtD
Naloxone—Skin disorder—Budesonide—ulcerative colitis	0.000208	0.00364	CcSEcCtD
Naloxone—Nervousness—Mesalazine—ulcerative colitis	0.000207	0.00362	CcSEcCtD
Naloxone—Hyperhidrosis—Budesonide—ulcerative colitis	0.000207	0.00362	CcSEcCtD
Naloxone—Irritability—Dexamethasone—ulcerative colitis	0.000205	0.00359	CcSEcCtD
Naloxone—Irritability—Betamethasone—ulcerative colitis	0.000205	0.00359	CcSEcCtD
Naloxone—Cardiac arrest—Dexamethasone—ulcerative colitis	0.000205	0.00358	CcSEcCtD
Naloxone—Cardiac arrest—Betamethasone—ulcerative colitis	0.000205	0.00358	CcSEcCtD
Naloxone—Vomiting—Mercaptopurine—ulcerative colitis	0.000204	0.00357	CcSEcCtD
Naloxone—Naltrexone—ABCB1—ulcerative colitis	0.000201	0.26	CrCbGaD
Naloxone—Tremor—Mesalazine—ulcerative colitis	0.0002	0.0035	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000198	0.00346	CcSEcCtD
Naloxone—Vomiting—Nicotine—ulcerative colitis	0.000198	0.00346	CcSEcCtD
Naloxone—Paraesthesia—Budesonide—ulcerative colitis	0.000192	0.00336	CcSEcCtD
Naloxone—ESR1—epithelium—ulcerative colitis	0.000192	0.0448	CbGeAlD
Naloxone—Dyspnoea—Budesonide—ulcerative colitis	0.000191	0.00334	CcSEcCtD
Naloxone—Nausea—Mercaptopurine—ulcerative colitis	0.00019	0.00333	CcSEcCtD
Naloxone—Skin disorder—Azathioprine—ulcerative colitis	0.000186	0.00325	CcSEcCtD
Naloxone—ESR1—smooth muscle tissue—ulcerative colitis	0.000185	0.0432	CbGeAlD
Naloxone—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000185	0.00323	CcSEcCtD
Naloxone—Nausea—Nicotine—ulcerative colitis	0.000185	0.00323	CcSEcCtD
Naloxone—Hypertension—Mesalazine—ulcerative colitis	0.000184	0.00322	CcSEcCtD
Naloxone—Pain—Budesonide—ulcerative colitis	0.000183	0.0032	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00018	0.00315	CcSEcCtD
Naloxone—Irritability—Prednisone—ulcerative colitis	0.000179	0.00313	CcSEcCtD
Naloxone—Cardiac arrest—Prednisone—ulcerative colitis	0.000178	0.00312	CcSEcCtD
Naloxone—Sweating—Methylprednisolone—ulcerative colitis	0.000175	0.00306	CcSEcCtD
Naloxone—Hallucination—Hydrocortisone—ulcerative colitis	0.000173	0.00303	CcSEcCtD
Naloxone—SLCO1A2—digestive system—ulcerative colitis	0.000172	0.0402	CbGeAlD
Naloxone—Nervous system disorder—Mesalazine—ulcerative colitis	0.000171	0.00299	CcSEcCtD
Naloxone—Tachycardia—Mesalazine—ulcerative colitis	0.00017	0.00297	CcSEcCtD
Naloxone—Abdominal pain—Budesonide—ulcerative colitis	0.000169	0.00296	CcSEcCtD
Naloxone—Body temperature increased—Budesonide—ulcerative colitis	0.000169	0.00296	CcSEcCtD
Naloxone—Skin disorder—Mesalazine—ulcerative colitis	0.000169	0.00296	CcSEcCtD
Naloxone—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000168	0.00294	CcSEcCtD
Naloxone—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000165	0.00289	CcSEcCtD
Naloxone—Hallucination—Methylprednisolone—ulcerative colitis	0.000163	0.00285	CcSEcCtD
Naloxone—Paraesthesia—Mesalazine—ulcerative colitis	0.000156	0.00273	CcSEcCtD
Naloxone—Dyspnoea—Mesalazine—ulcerative colitis	0.000155	0.00271	CcSEcCtD
Naloxone—Asthenia—Budesonide—ulcerative colitis	0.000154	0.00269	CcSEcCtD
Naloxone—Mental disorder—Hydrocortisone—ulcerative colitis	0.000153	0.00267	CcSEcCtD
Naloxone—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000152	0.00266	CcSEcCtD
Naloxone—Body temperature increased—Azathioprine—ulcerative colitis	0.000151	0.00264	CcSEcCtD
Naloxone—Abdominal pain—Azathioprine—ulcerative colitis	0.000151	0.00264	CcSEcCtD
Naloxone—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00015	0.00263	CcSEcCtD
Naloxone—Pain—Mesalazine—ulcerative colitis	0.000149	0.0026	CcSEcCtD
Naloxone—Angiopathy—Methylprednisolone—ulcerative colitis	0.000148	0.0026	CcSEcCtD
Naloxone—Hallucination—Betamethasone—ulcerative colitis	0.000148	0.00259	CcSEcCtD
Naloxone—Hallucination—Dexamethasone—ulcerative colitis	0.000148	0.00259	CcSEcCtD
Naloxone—ESR1—lymphoid tissue—ulcerative colitis	0.000148	0.0345	CbGeAlD
Naloxone—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000147	0.00258	CcSEcCtD
Naloxone—Buprenorphine—ABCB1—ulcerative colitis	0.000147	0.191	CrCbGaD
Naloxone—Diarrhoea—Budesonide—ulcerative colitis	0.000146	0.00256	CcSEcCtD
Naloxone—ESR1—digestive system—ulcerative colitis	0.000146	0.0341	CbGeAlD
Naloxone—Depression—Prednisone—ulcerative colitis	0.000144	0.00252	CcSEcCtD
Naloxone—Mental disorder—Methylprednisolone—ulcerative colitis	0.000143	0.00251	CcSEcCtD
Naloxone—Abdominal pain—Mesalazine—ulcerative colitis	0.000138	0.00241	CcSEcCtD
Naloxone—Body temperature increased—Mesalazine—ulcerative colitis	0.000138	0.00241	CcSEcCtD
Naloxone—Vomiting—Budesonide—ulcerative colitis	0.000136	0.00238	CcSEcCtD
Naloxone—Angiopathy—Dexamethasone—ulcerative colitis	0.000135	0.00236	CcSEcCtD
Naloxone—Angiopathy—Betamethasone—ulcerative colitis	0.000135	0.00236	CcSEcCtD
Naloxone—Convulsion—Prednisolone—ulcerative colitis	0.000134	0.00235	CcSEcCtD
Naloxone—Hypertension—Prednisolone—ulcerative colitis	0.000134	0.00235	CcSEcCtD
Naloxone—Convulsion—Hydrocortisone—ulcerative colitis	0.000131	0.0023	CcSEcCtD
Naloxone—Hypertension—Hydrocortisone—ulcerative colitis	0.000131	0.00229	CcSEcCtD
Naloxone—Diarrhoea—Azathioprine—ulcerative colitis	0.000131	0.00229	CcSEcCtD
Naloxone—Hallucination—Prednisone—ulcerative colitis	0.000129	0.00226	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000128	0.00224	CcSEcCtD
Naloxone—SLCO1A2—liver—ulcerative colitis	0.000128	0.0299	CbGeAlD
Naloxone—ALB—liver—ulcerative colitis	0.000127	0.0298	CbGeAlD
Naloxone—Nausea—Budesonide—ulcerative colitis	0.000127	0.00222	CcSEcCtD
Naloxone—Asthenia—Mesalazine—ulcerative colitis	0.000125	0.00218	CcSEcCtD
Naloxone—Convulsion—Triamcinolone—ulcerative colitis	0.000124	0.00216	CcSEcCtD
Naloxone—Tachycardia—Prednisolone—ulcerative colitis	0.000124	0.00216	CcSEcCtD
Naloxone—Morphine—ABCB1—ulcerative colitis	0.000124	0.16	CrCbGaD
Naloxone—Convulsion—Methylprednisolone—ulcerative colitis	0.000123	0.00216	CcSEcCtD
Naloxone—Hypertension—Triamcinolone—ulcerative colitis	0.000123	0.00216	CcSEcCtD
Naloxone—Hypertension—Methylprednisolone—ulcerative colitis	0.000123	0.00215	CcSEcCtD
Naloxone—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000122	0.00214	CcSEcCtD
Naloxone—Vomiting—Azathioprine—ulcerative colitis	0.000121	0.00213	CcSEcCtD
Naloxone—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000121	0.00212	CcSEcCtD
Naloxone—Tachycardia—Hydrocortisone—ulcerative colitis	0.000121	0.00211	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00012	0.00211	CcSEcCtD
Naloxone—Flushing—Prednisone—ulcerative colitis	0.00012	0.0021	CcSEcCtD
Naloxone—Skin disorder—Hydrocortisone—ulcerative colitis	0.00012	0.0021	CcSEcCtD
Naloxone—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00012	0.00209	CcSEcCtD
Naloxone—Diarrhoea—Mesalazine—ulcerative colitis	0.000119	0.00208	CcSEcCtD
Naloxone—Angiopathy—Prednisone—ulcerative colitis	0.000118	0.00206	CcSEcCtD
Naloxone—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000114	0.002	CcSEcCtD
Naloxone—Paraesthesia—Prednisolone—ulcerative colitis	0.000114	0.00199	CcSEcCtD
Naloxone—Tachycardia—Triamcinolone—ulcerative colitis	0.000114	0.00199	CcSEcCtD
Naloxone—Mental disorder—Prednisone—ulcerative colitis	0.000114	0.00199	CcSEcCtD
Naloxone—Nausea—Azathioprine—ulcerative colitis	0.000113	0.00199	CcSEcCtD
Naloxone—Tachycardia—Methylprednisolone—ulcerative colitis	0.000113	0.00199	CcSEcCtD
Naloxone—Skin disorder—Methylprednisolone—ulcerative colitis	0.000113	0.00198	CcSEcCtD
Naloxone—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000113	0.00197	CcSEcCtD
Naloxone—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000112	0.00197	CcSEcCtD
Naloxone—Convulsion—Betamethasone—ulcerative colitis	0.000112	0.00196	CcSEcCtD
Naloxone—Convulsion—Dexamethasone—ulcerative colitis	0.000112	0.00196	CcSEcCtD
Naloxone—Hypertension—Betamethasone—ulcerative colitis	0.000112	0.00196	CcSEcCtD
Naloxone—Hypertension—Dexamethasone—ulcerative colitis	0.000112	0.00196	CcSEcCtD
Naloxone—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000111	0.00194	CcSEcCtD
Naloxone—Vomiting—Mesalazine—ulcerative colitis	0.000111	0.00194	CcSEcCtD
Naloxone—ESR1—liver—ulcerative colitis	0.000109	0.0254	CbGeAlD
Naloxone—Pain—Prednisolone—ulcerative colitis	0.000108	0.0019	CcSEcCtD
Naloxone—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000107	0.00187	CcSEcCtD
Naloxone—Pain—Hydrocortisone—ulcerative colitis	0.000106	0.00185	CcSEcCtD
Naloxone—Paraesthesia—Triamcinolone—ulcerative colitis	0.000105	0.00183	CcSEcCtD
Naloxone—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000104	0.00183	CcSEcCtD
Naloxone—Dyspnoea—Triamcinolone—ulcerative colitis	0.000104	0.00182	CcSEcCtD
Naloxone—Nervous system disorder—Betamethasone—ulcerative colitis	0.000104	0.00181	CcSEcCtD
Naloxone—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000104	0.00181	CcSEcCtD
Naloxone—Agitation—Prednisone—ulcerative colitis	0.000104	0.00181	CcSEcCtD
Naloxone—Nausea—Mesalazine—ulcerative colitis	0.000103	0.00181	CcSEcCtD
Naloxone—Tachycardia—Dexamethasone—ulcerative colitis	0.000103	0.00181	CcSEcCtD
Naloxone—Tachycardia—Betamethasone—ulcerative colitis	0.000103	0.00181	CcSEcCtD
Naloxone—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000102	0.00179	CcSEcCtD
Naloxone—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000102	0.00179	CcSEcCtD
Naloxone—Pain—Triamcinolone—ulcerative colitis	9.96e-05	0.00174	CcSEcCtD
Naloxone—Abdominal pain—Hydrocortisone—ulcerative colitis	9.78e-05	0.00171	CcSEcCtD
Naloxone—Body temperature increased—Hydrocortisone—ulcerative colitis	9.78e-05	0.00171	CcSEcCtD
Naloxone—Convulsion—Prednisone—ulcerative colitis	9.77e-05	0.00171	CcSEcCtD
Naloxone—Hypertension—Prednisone—ulcerative colitis	9.74e-05	0.0017	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	9.54e-05	0.00167	CcSEcCtD
Naloxone—Paraesthesia—Betamethasone—ulcerative colitis	9.49e-05	0.00166	CcSEcCtD
Naloxone—Paraesthesia—Dexamethasone—ulcerative colitis	9.49e-05	0.00166	CcSEcCtD
Naloxone—Body temperature increased—Triamcinolone—ulcerative colitis	9.21e-05	0.00161	CcSEcCtD
Naloxone—Abdominal pain—Methylprednisolone—ulcerative colitis	9.19e-05	0.00161	CcSEcCtD
Naloxone—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.13e-05	0.0016	CcSEcCtD
Naloxone—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.13e-05	0.0016	CcSEcCtD
Naloxone—Pain—Betamethasone—ulcerative colitis	9.04e-05	0.00158	CcSEcCtD
Naloxone—Pain—Dexamethasone—ulcerative colitis	9.04e-05	0.00158	CcSEcCtD
Naloxone—Nervous system disorder—Prednisone—ulcerative colitis	9.03e-05	0.00158	CcSEcCtD
Naloxone—Tachycardia—Prednisone—ulcerative colitis	8.98e-05	0.00157	CcSEcCtD
Naloxone—CYP2C8—liver—ulcerative colitis	8.95e-05	0.0209	CbGeAlD
Naloxone—Skin disorder—Prednisone—ulcerative colitis	8.94e-05	0.00156	CcSEcCtD
Naloxone—Hyperhidrosis—Prednisone—ulcerative colitis	8.9e-05	0.00156	CcSEcCtD
Naloxone—Asthenia—Hydrocortisone—ulcerative colitis	8.88e-05	0.00155	CcSEcCtD
Naloxone—Diarrhoea—Hydrocortisone—ulcerative colitis	8.47e-05	0.00148	CcSEcCtD
Naloxone—Asthenia—Triamcinolone—ulcerative colitis	8.36e-05	0.00146	CcSEcCtD
Naloxone—Body temperature increased—Dexamethasone—ulcerative colitis	8.36e-05	0.00146	CcSEcCtD
Naloxone—Body temperature increased—Betamethasone—ulcerative colitis	8.36e-05	0.00146	CcSEcCtD
Naloxone—Abdominal pain—Dexamethasone—ulcerative colitis	8.36e-05	0.00146	CcSEcCtD
Naloxone—Abdominal pain—Betamethasone—ulcerative colitis	8.36e-05	0.00146	CcSEcCtD
Naloxone—Asthenia—Methylprednisolone—ulcerative colitis	8.34e-05	0.00146	CcSEcCtD
Naloxone—Paraesthesia—Prednisone—ulcerative colitis	8.27e-05	0.00145	CcSEcCtD
Naloxone—CYP3A4—digestive system—ulcerative colitis	8.14e-05	0.019	CbGeAlD
Naloxone—Diarrhoea—Methylprednisolone—ulcerative colitis	7.95e-05	0.00139	CcSEcCtD
Naloxone—Vomiting—Hydrocortisone—ulcerative colitis	7.87e-05	0.00138	CcSEcCtD
Naloxone—Asthenia—Betamethasone—ulcerative colitis	7.58e-05	0.00133	CcSEcCtD
Naloxone—Asthenia—Dexamethasone—ulcerative colitis	7.58e-05	0.00133	CcSEcCtD
Naloxone—ABCB1—epithelium—ulcerative colitis	7.57e-05	0.0177	CbGeAlD
Naloxone—Nausea—Prednisolone—ulcerative colitis	7.53e-05	0.00132	CcSEcCtD
Naloxone—Vomiting—Triamcinolone—ulcerative colitis	7.41e-05	0.0013	CcSEcCtD
Naloxone—Vomiting—Methylprednisolone—ulcerative colitis	7.39e-05	0.00129	CcSEcCtD
Naloxone—Nausea—Hydrocortisone—ulcerative colitis	7.35e-05	0.00129	CcSEcCtD
Naloxone—Abdominal pain—Prednisone—ulcerative colitis	7.28e-05	0.00127	CcSEcCtD
Naloxone—Body temperature increased—Prednisone—ulcerative colitis	7.28e-05	0.00127	CcSEcCtD
Naloxone—Diarrhoea—Dexamethasone—ulcerative colitis	7.23e-05	0.00127	CcSEcCtD
Naloxone—Diarrhoea—Betamethasone—ulcerative colitis	7.23e-05	0.00127	CcSEcCtD
Naloxone—Nausea—Triamcinolone—ulcerative colitis	6.92e-05	0.00121	CcSEcCtD
Naloxone—Nausea—Methylprednisolone—ulcerative colitis	6.9e-05	0.00121	CcSEcCtD
Naloxone—Vomiting—Dexamethasone—ulcerative colitis	6.72e-05	0.00118	CcSEcCtD
Naloxone—Vomiting—Betamethasone—ulcerative colitis	6.72e-05	0.00118	CcSEcCtD
Naloxone—Asthenia—Prednisone—ulcerative colitis	6.61e-05	0.00116	CcSEcCtD
Naloxone—Diarrhoea—Prednisone—ulcerative colitis	6.3e-05	0.0011	CcSEcCtD
Naloxone—Nausea—Betamethasone—ulcerative colitis	6.28e-05	0.0011	CcSEcCtD
Naloxone—Nausea—Dexamethasone—ulcerative colitis	6.28e-05	0.0011	CcSEcCtD
Naloxone—CYP3A4—liver—ulcerative colitis	6.06e-05	0.0142	CbGeAlD
Naloxone—Vomiting—Prednisone—ulcerative colitis	5.85e-05	0.00102	CcSEcCtD
Naloxone—ABCB1—lymphoid tissue—ulcerative colitis	5.83e-05	0.0136	CbGeAlD
Naloxone—ABCB1—digestive system—ulcerative colitis	5.76e-05	0.0135	CbGeAlD
Naloxone—Nausea—Prednisone—ulcerative colitis	5.47e-05	0.000957	CcSEcCtD
Naloxone—ABCB1—liver—ulcerative colitis	4.29e-05	0.01	CbGeAlD
Naloxone—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	1.6e-05	0.000167	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—HNF4A—ulcerative colitis	1.6e-05	0.000167	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	1.6e-05	0.000167	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—ADCY5—ulcerative colitis	1.57e-05	0.000164	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	1.56e-05	0.000163	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MAML2—ulcerative colitis	1.56e-05	0.000163	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MAML2—ulcerative colitis	1.55e-05	0.000162	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	1.54e-05	0.000161	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.54e-05	0.000161	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—JAK2—ulcerative colitis	1.53e-05	0.00016	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.53e-05	0.000159	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	1.52e-05	0.000159	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	1.52e-05	0.000159	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.51e-05	0.000158	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.51e-05	0.000158	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.5e-05	0.000157	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.5e-05	0.000157	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.5e-05	0.000157	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—IL6—ulcerative colitis	1.5e-05	0.000156	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CALM3—ulcerative colitis	1.49e-05	0.000155	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—RELA—ulcerative colitis	1.48e-05	0.000155	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCR1—ulcerative colitis	1.45e-05	0.000152	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD4—ulcerative colitis	1.45e-05	0.000152	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—PPARG—ulcerative colitis	1.44e-05	0.000151	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	1.44e-05	0.00015	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTGER4—ulcerative colitis	1.44e-05	0.00015	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	1.43e-05	0.00015	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP9—ulcerative colitis	1.43e-05	0.00015	CbGpPWpGaD
Naloxone—CREB1—Immune System—ADCY5—ulcerative colitis	1.43e-05	0.00015	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	1.43e-05	0.000149	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—RELA—ulcerative colitis	1.42e-05	0.000149	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—NFKB1—ulcerative colitis	1.42e-05	0.000148	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CHP1—ulcerative colitis	1.41e-05	0.000147	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	1.4e-05	0.000146	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD4—ulcerative colitis	1.39e-05	0.000146	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—DLD—ulcerative colitis	1.39e-05	0.000146	CbGpPWpGaD
Naloxone—ALB—Metabolism—DLD—ulcerative colitis	1.39e-05	0.000145	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—IL6—ulcerative colitis	1.38e-05	0.000144	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS1—ulcerative colitis	1.37e-05	0.000143	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	1.37e-05	0.000143	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	1.36e-05	0.000142	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.36e-05	0.000142	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	1.35e-05	0.000141	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	1.35e-05	0.000141	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.35e-05	0.000141	CbGpPWpGaD
Naloxone—CREB1—Disease—ADCY5—ulcerative colitis	1.32e-05	0.000138	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GHRL—ulcerative colitis	1.32e-05	0.000138	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	1.31e-05	0.000137	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL6—ulcerative colitis	1.31e-05	0.000137	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	1.31e-05	0.000136	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	1.28e-05	0.000134	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	1.28e-05	0.000134	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.28e-05	0.000134	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL20—ulcerative colitis	1.28e-05	0.000133	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CALM3—ulcerative colitis	1.28e-05	0.000133	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.27e-05	0.000133	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—STAT3—ulcerative colitis	1.27e-05	0.000133	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	1.27e-05	0.000133	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	1.26e-05	0.000131	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RIPK2—ulcerative colitis	1.26e-05	0.000131	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	1.25e-05	0.000131	CbGpPWpGaD
Naloxone—CREB1—Immune System—CRP—ulcerative colitis	1.25e-05	0.000131	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—NFKB1—ulcerative colitis	1.25e-05	0.000131	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—IL6—ulcerative colitis	1.25e-05	0.00013	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CALM3—ulcerative colitis	1.23e-05	0.000129	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—DLD—ulcerative colitis	1.21e-05	0.000127	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.21e-05	0.000126	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	1.21e-05	0.000126	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—NFKB1—ulcerative colitis	1.2e-05	0.000126	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNA12—ulcerative colitis	1.2e-05	0.000125	CbGpPWpGaD
Naloxone—CREB1—Immune System—TLR4—ulcerative colitis	1.2e-05	0.000125	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DRB1—ulcerative colitis	1.2e-05	0.000125	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TGFB1—ulcerative colitis	1.18e-05	0.000123	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.18e-05	0.000123	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	1.16e-05	0.000121	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	1.15e-05	0.00012	CbGpPWpGaD
Naloxone—CREB1—Immune System—ICAM1—ulcerative colitis	1.15e-05	0.00012	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	1.14e-05	0.00012	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.14e-05	0.000119	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCR2—ulcerative colitis	1.14e-05	0.000119	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	1.11e-05	0.000116	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—ulcerative colitis	1.1e-05	0.000115	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	1.1e-05	0.000115	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ADRB2—ulcerative colitis	1.09e-05	0.000114	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	1.09e-05	0.000114	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	1.07e-05	0.000112	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR6—ulcerative colitis	1.07e-05	0.000112	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	1.06e-05	0.000111	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.05e-05	0.00011	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDH1—ulcerative colitis	1.02e-05	0.000106	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MAML2—ulcerative colitis	1.01e-05	0.000106	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1e-05	0.000105	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—VDR—ulcerative colitis	9.97e-06	0.000104	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	9.78e-06	0.000102	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—JAK2—ulcerative colitis	9.77e-06	0.000102	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	9.73e-06	0.000102	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	9.73e-06	0.000102	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ABCB1—ulcerative colitis	9.6e-06	0.0001	CbGpPWpGaD
Naloxone—ALB—Hemostasis—MMP1—ulcerative colitis	9.55e-06	9.98e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	9.53e-06	9.95e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	9.42e-06	9.84e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTGER4—ulcerative colitis	9.42e-06	9.84e-05	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	9.4e-06	9.82e-05	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	9.35e-06	9.77e-05	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.35e-06	9.76e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	9.28e-06	9.7e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ADCY5—ulcerative colitis	9.25e-06	9.67e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	9.22e-06	9.64e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ADCY5—ulcerative colitis	8.96e-06	9.36e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—JAK2—ulcerative colitis	8.92e-06	9.32e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CXCL8—ulcerative colitis	8.91e-06	9.31e-05	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—IL6—ulcerative colitis	8.89e-06	9.29e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	8.88e-06	9.28e-05	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	8.88e-06	9.28e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IFNG—ulcerative colitis	8.76e-06	9.15e-05	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	8.75e-06	9.14e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CHP1—ulcerative colitis	8.67e-06	9.06e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—RELA—ulcerative colitis	8.64e-06	9.03e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GHRL—ulcerative colitis	8.63e-06	9.01e-05	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	8.58e-06	8.96e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	8.54e-06	8.92e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL2—ulcerative colitis	8.52e-06	8.9e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	8.49e-06	8.87e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD4—ulcerative colitis	8.46e-06	8.84e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CALM3—ulcerative colitis	8.35e-06	8.73e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—JAK2—ulcerative colitis	8.24e-06	8.61e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RIPK2—ulcerative colitis	8.23e-06	8.6e-05	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	8.2e-06	8.56e-05	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	8.19e-06	8.55e-05	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	8.17e-06	8.53e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	8.09e-06	8.45e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	8.05e-06	8.41e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	7.94e-06	8.3e-05	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IL6—ulcerative colitis	7.85e-06	8.2e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1B—ulcerative colitis	7.81e-06	8.16e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—CD4—ulcerative colitis	7.81e-06	8.16e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	7.79e-06	8.14e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL2—ulcerative colitis	7.78e-06	8.13e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—PTGS2—ulcerative colitis	7.75e-06	8.1e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—DLD—ulcerative colitis	7.48e-06	7.82e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	7.44e-06	7.78e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.37e-06	7.7e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.33e-06	7.66e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—NFKB1—ulcerative colitis	7.29e-06	7.61e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	7.25e-06	7.57e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	7.21e-06	7.54e-05	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.2e-06	7.52e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ADRB2—ulcerative colitis	7.14e-06	7.46e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—PPARG—ulcerative colitis	6.95e-06	7.26e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	6.93e-06	7.24e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	6.84e-06	7.14e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS1—ulcerative colitis	6.74e-06	7.04e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—JAK2—ulcerative colitis	6.73e-06	7.03e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS1—ulcerative colitis	6.7e-06	7e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PPARG—ulcerative colitis	6.68e-06	6.98e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.63e-06	6.92e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	6.58e-06	6.88e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—STAT3—ulcerative colitis	6.55e-06	6.84e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	6.29e-06	6.57e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.07e-06	6.34e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ADCY5—ulcerative colitis	6.06e-06	6.33e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—STAT3—ulcerative colitis	6.05e-06	6.32e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CALM3—ulcerative colitis	6.03e-06	6.3e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ALB—ulcerative colitis	6.01e-06	6.28e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS1—ulcerative colitis	5.87e-06	6.13e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IL2—ulcerative colitis	5.87e-06	6.13e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.8e-06	6.06e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—JAK2—ulcerative colitis	5.77e-06	6.03e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.77e-06	6.02e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	5.75e-06	6.01e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—ulcerative colitis	5.6e-06	5.85e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RELA—ulcerative colitis	5.59e-06	5.84e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RELA—ulcerative colitis	5.57e-06	5.82e-05	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.49e-06	5.74e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CALM3—ulcerative colitis	5.29e-06	5.52e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CXCL8—ulcerative colitis	5.26e-06	5.5e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PTGS2—ulcerative colitis	5.26e-06	5.49e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	5.25e-06	5.48e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	5.04e-06	5.27e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL2—ulcerative colitis	5.03e-06	5.26e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL2—ulcerative colitis	5.02e-06	5.24e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—ulcerative colitis	5.01e-06	5.23e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	4.99e-06	5.21e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RELA—ulcerative colitis	4.88e-06	5.1e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—ulcerative colitis	4.76e-06	4.97e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	4.75e-06	4.96e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCB1—ulcerative colitis	4.72e-06	4.93e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NFKB1—ulcerative colitis	4.71e-06	4.92e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	4.7e-06	4.91e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCB1—ulcerative colitis	4.69e-06	4.9e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	4.6e-06	4.81e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—ulcerative colitis	4.58e-06	4.78e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—ulcerative colitis	4.57e-06	4.78e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.4e-06	4.6e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL2—ulcerative colitis	4.4e-06	4.59e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ADCY5—ulcerative colitis	4.38e-06	4.57e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	4.38e-06	4.57e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	4.26e-06	4.45e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—STAT3—ulcerative colitis	4.23e-06	4.42e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—ulcerative colitis	4.22e-06	4.41e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	4.22e-06	4.41e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	4.16e-06	4.35e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RELA—ulcerative colitis	4.13e-06	4.31e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	4.12e-06	4.3e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—ulcerative colitis	3.92e-06	4.1e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	3.91e-06	4.09e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	3.89e-06	4.06e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ADCY5—ulcerative colitis	3.84e-06	4.01e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—JAK2—ulcerative colitis	3.78e-06	3.95e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—ulcerative colitis	3.77e-06	3.94e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL2—ulcerative colitis	3.72e-06	3.88e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	3.7e-06	3.87e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	3.7e-06	3.86e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RELA—ulcerative colitis	3.66e-06	3.82e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.62e-06	3.78e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	3.52e-06	3.67e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	3.48e-06	3.64e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CXCL8—ulcerative colitis	3.45e-06	3.6e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	3.43e-06	3.58e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL2—ulcerative colitis	3.3e-06	3.44e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.28e-06	3.43e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PPARG—ulcerative colitis	3.26e-06	3.41e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.26e-06	3.4e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—ulcerative colitis	3.23e-06	3.38e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—ulcerative colitis	3.22e-06	3.36e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	3.13e-06	3.27e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—ulcerative colitis	3.12e-06	3.26e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NFKB1—ulcerative colitis	3.09e-06	3.22e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—ulcerative colitis	2.96e-06	3.09e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALB—ulcerative colitis	2.95e-06	3.08e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—ulcerative colitis	2.95e-06	3.08e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	2.9e-06	3.03e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PPARG—ulcerative colitis	2.86e-06	2.99e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—ulcerative colitis	2.82e-06	2.95e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—STAT3—ulcerative colitis	2.77e-06	2.9e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—ulcerative colitis	2.59e-06	2.7e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.58e-06	2.7e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALB—ulcerative colitis	2.57e-06	2.69e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—ulcerative colitis	2.57e-06	2.69e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PTGS2—ulcerative colitis	2.57e-06	2.68e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.53e-06	2.65e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—ulcerative colitis	2.39e-06	2.49e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.36e-06	2.47e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.25e-06	2.35e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—ulcerative colitis	2.18e-06	2.28e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—ulcerative colitis	2.12e-06	2.21e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—ulcerative colitis	1.94e-06	2.02e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.76e-06	1.84e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALB—ulcerative colitis	1.58e-06	1.66e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.39e-06	1.45e-05	CbGpPWpGaD
